The Effect of Nicardipine on Kidney Function During Orthognathic Surgery Under Hypotensive Anesthesia
Information source: Yonsei University
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Healthy Subjects
Intervention: Nicardipine (Drug); remifentanil (Drug)
Phase: N/A
Status: Completed
Sponsored by: Yonsei University Official(s) and/or principal investigator(s): Ji Young Kim, Principal Investigator, Affiliation: Severance hospital, YUHS
Summary
Since nicardipine is known to protect kidney function, nicardipine infusion will result in
better renal parameters measured in this study.
Clinical Details
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention
Primary outcome: Creatinine Clearance
Eligibility
Minimum age: 20 Years.
Maximum age: 40 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- healthy adult patients undergoing hypotensive anesthesia
Exclusion Criteria:
- patients with any co-morbidity
Locations and Contacts
Additional Information
Starting date: August 2010
Last updated: June 11, 2013
|